Generalization of deep learning models for ultra-low-count amyloid PET/MRI using transfer learning

Purpose We aimed to evaluate the performance of deep learning-based generalization of ultra-low-count amyloid PET/MRI enhancement when applied to studies acquired with different scanning hardware and protocols. Methods Eighty simultaneous [ 18 F]florbetaben PET/MRI studies were acquired, split equally between two sites (site 1: Signa PET/MRI, GE Healthcare, 39 participants, 67 ± 8 years, 23 females; site 2: mMR, Siemens Healthineers, 64 ± 11 years, 23 females) with different MRI protocols. Twenty minutes of list-mode PET data (90–110 min post-injection) were reconstructed as ground-truth. Ultra-low-count data obtained from undersampling by a factor of 100 (site 1) or the first minute of PET acquisition (site 2) were reconstructed for ultra-low-dose/ultra-short-time (1% dose and 5% time, respectively) PET images. A deep convolution neural network was pre-trained with site 1 data and either (A) directly applied or (B) trained further on site 2 data using transfer learning. Networks were also trained from scratch based on (C) site 2 data or (D) all data. Certified physicians determined amyloid uptake (+/−) status for accuracy and scored the image quality. The peak signal-to-noise ratio, structural similarity, and root-mean-squared error were calculated between images and their ground-truth counterparts. Mean regional standardized uptake value ratios (SUVR, reference region: cerebellar cortex) from 37 successful site 2 FreeSurfer segmentations were analyzed. Results All network-synthesized images had reduced noise than their ultra-low-count reconstructions. Quantitatively, image metrics improved the most using method B, where SUVRs had the least variability from the ground-truth and the highest effect size to differentiate between positive and negative images. Method A images had lower accuracy and image quality than other methods; images synthesized from methods B–D scored similarly or better than the ground-truth images. Conclusions Deep learning can successfully produce diagnostic amyloid PET images from short frame reconstructions. Data bias should be considered when applying pre-trained deep ultra-low-count amyloid PET/MRI networks for generalization.

[1]  Razvan Pascanu,et al.  Overcoming catastrophic forgetting in neural networks , 2016, Proceedings of the National Academy of Sciences.

[2]  Feng Lin,et al.  Low-Dose CT With a Residual Encoder-Decoder Convolutional Neural Network , 2017, IEEE Transactions on Medical Imaging.

[3]  Anders M. Dale,et al.  An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest , 2006, NeuroImage.

[4]  Victor L. Villemagne,et al.  Brain Amyloid Imaging , 2011, The Journal of Nuclear Medicine.

[5]  L. Frings,et al.  Limits for Reduction of Acquisition Time and Administered Activity in 18F-FDG PET Studies of Alzheimer Dementia and Frontotemporal Dementia , 2019, The Journal of Nuclear Medicine.

[6]  Thomas Brox,et al.  U-Net: Convolutional Networks for Biomedical Image Segmentation , 2015, MICCAI.

[7]  John Seibyl,et al.  Cerebral amyloid-β PET with florbetaben (18F) in patients with Alzheimer's disease and healthy controls: a multicentre phase 2 diagnostic study , 2011, The Lancet Neurology.

[8]  Victor L Villemagne Selective Tau Imaging: Der Stand der Dinge* , 2017, The Journal of Nuclear Medicine.

[9]  Satrajit S. Ghosh,et al.  Distributed Weight Consolidation: A Brain Segmentation Case Study , 2018, NeurIPS.

[10]  Keith A. Johnson,et al.  The impact of amyloid‐beta and tau on prospective cognitive decline in older individuals , 2018, Annals of neurology.

[11]  R. French Catastrophic forgetting in connectionist networks , 1999, Trends in Cognitive Sciences.

[12]  S. Holm,et al.  Region specific optimization of continuous linear attenuation coefficients based on UTE (RESOLUTE): application to PET/MR brain imaging , 2015, Physics in medicine and biology.

[13]  Dinggang Shen,et al.  Deep auto-context convolutional neural networks for standard-dose PET image estimation from low-dose PET/MRI , 2017, Neurocomputing.

[14]  John M Pauly,et al.  Ultra-Low-Dose 18F-Florbetaben Amyloid PET Imaging Using Deep Learning with Multi-Contrast MRI Inputs. , 2019, Radiology.

[15]  Konstantin Nikolaou,et al.  Towards tracer dose reduction in PET studies: Simulation of dose reduction by retrospective randomized undersampling of list-mode data. , 2016, Hellenic journal of nuclear medicine.

[16]  Alexander Hammers,et al.  MR-Guided Kernel EM Reconstruction for Reduced Dose PET Imaging , 2018, IEEE Transactions on Radiation and Plasma Medical Sciences.

[17]  Swen Hesse,et al.  Influence of scan duration on the accuracy of β-amyloid PET with florbetaben in patients with Alzheimer’s disease and healthy volunteers , 2012, European Journal of Nuclear Medicine and Molecular Imaging.

[18]  Mannudeep K. Kalra,et al.  Low-Dose CT with a Residual Encoder-Decoder Convolutional Neural Network (RED-CNN) , 2017, ArXiv.

[19]  A. Dale,et al.  Cortical Surface-Based Analysis II: Inflation, Flattening, and a Surface-Based Coordinate System , 1999, NeuroImage.

[20]  Jacob Cohen Statistical Power Analysis for the Behavioral Sciences , 1969, The SAGE Encyclopedia of Research Design.

[21]  Ciprian Catana,et al.  PET/MRI for Neurologic Applications , 2012, The Journal of Nuclear Medicine.

[22]  Osama Sabri,et al.  Potential Clinical Applications of PET/MR Imaging in Neurodegenerative Diseases , 2014, The Journal of Nuclear Medicine.

[23]  Garry Gold,et al.  Simultaneous Whole-Body Time-of-Flight 18F-FDG PET/MRI: A Pilot Study Comparing SUVmax With PET/CT and Assessment of MR Image Quality , 2015, Clinical nuclear medicine.

[24]  J. Morris,et al.  The Cortical Signature of Alzheimer's Disease: Regionally Specific Cortical Thinning Relates to Symptom Severity in Very Mild to Mild AD Dementia and is Detectable in Asymptomatic Amyloid-Positive Individuals , 2008, Cerebral cortex.

[25]  Brian B. Avants,et al.  The Multimodal Brain Tumor Image Segmentation Benchmark (BRATS) , 2015, IEEE Transactions on Medical Imaging.

[26]  Qiang Yang,et al.  A Survey on Transfer Learning , 2010, IEEE Transactions on Knowledge and Data Engineering.

[27]  Maged Goubran,et al.  Predicting 15O-Water PET cerebral blood flow maps from multi-contrast MRI using a deep convolutional neural network with evaluation of training cohort bias , 2019, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[28]  Osama Sabri,et al.  PET/MR in dementia and other neurodegenerative diseases. , 2015, Seminars in nuclear medicine.

[29]  Bruce R. Rosen,et al.  Distributed deep learning networks among institutions for medical imaging , 2018, J. Am. Medical Informatics Assoc..

[30]  K. Herholz,et al.  The effect of 18F-florbetapir dose reduction on region-based classification of cortical amyloid deposition , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[31]  Spyridon Bakas,et al.  Multi-Institutional Deep Learning Modeling Without Sharing Patient Data: A Feasibility Study on Brain Tumor Segmentation , 2018, BrainLes@MICCAI.

[32]  Eero P. Simoncelli,et al.  Image quality assessment: from error visibility to structural similarity , 2004, IEEE Transactions on Image Processing.

[33]  Anders M. Dale,et al.  Cortical Surface-Based Analysis I. Segmentation and Surface Reconstruction , 1999, NeuroImage.

[34]  Jong Chul Ye,et al.  Deep Convolutional Framelets: A General Deep Learning Framework for Inverse Problems , 2017, SIAM J. Imaging Sci..

[35]  E. DeLong,et al.  Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. , 1988, Biometrics.

[36]  S. Dwivedi,et al.  Obesity May Be Bad: Compressed Convolutional Networks for Biomedical Image Segmentation , 2020 .

[37]  C. Jack,et al.  NIA-AA Research Framework: Toward a biological definition of Alzheimer’s disease , 2018, Alzheimer's & Dementia.